Emergent BioSolutions EBS
NYSE EBS
$6.76 +0.21 (+3.21%)
At close: Sep 22, 2026 · 4:00 PM EDT

Emergent BioSolutions (EBS) Operating Margin (2011 - 2026)

Emergent BioSolutions (EBS) posted Operating Margin of 53.39% for Q2 2026, down 893.78% on a QoQ basis from 6.73% in Q1 2026, and down 5453.0% year-over-year from 1.0% in Q2 2025.

Analysis

Emergent BioSolutions (EBS) Operating Margin (2011 - 2026) Analysis & Trends

Emergent BioSolutions has reported Operating Margin for 16 years, with the latest figure at 53.39% in Q2 2026.

  • On a quarterly basis, Operating Margin fell 5453.0% year-over-year to 53.39% in Q2 2026; TTM through Jun 2026 was 8.57%, a 2108.0% decrease from a year earlier, with the FY2025 full-year figure at 13.47%, up 2389.0% from the prior year.
  • Operating Margin was 53.39% for Q2 2026 at Emergent BioSolutions, down from 6.73% in the prior quarter.
  • The five-year high for Operating Margin was 33.1% in Q3 2025, with the low at 89.84% in Q1 2023.
  • Average Operating Margin over 5 years is 22.5%, with a median of 16.29% recorded in 2022.
  • The sharpest annual moves came in 2023 and 2024: Operating Margin slumped 9210 bps in 2023, then surged 11145 bps in 2024.
  • Over 5 years, Operating Margin stood at 16.75% in 2022, then grew by 5 bps to 15.84% in 2023, then soared by 69 bps to 4.88% in 2024, then tumbled by 285 bps to 18.76% in 2025, then tumbled by 185 bps to 53.39% in 2026.
  • The last three Operating Margin figures came in at 53.39% (Q2 2026), 6.73% (Q1 2026), and 18.76% (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Operating Margin (Qtr)
1 Johnson & Johnson 649.47 Bn 628.71 Bn 17.26 Bn 28.21%
2 AbbVie 467.46 Bn 460.93 Bn 12.70 Bn 37.86%
3 Merck 369.31 Bn 362.22 Bn 12.21 Bn -3.52%
4 Novartis Ag 269.03 Bn 261.74 Bn 11.24 Bn 32.97%
5 Pfizer 158.11 Bn 146.71 Bn 10.94 Bn 28.37%
6 Bristol Myers Squibb 127.96 Bn 116.89 Bn 9.25 Bn 2.77%
7 Sanofi 51.83 Bn 44.86 Bn 10.79 Bn 9.03%
8 BeOne Medicines 41.33 Bn 36.23 Bn 1.53 Bn 19.06%
9 Revolution Medicines 41.30 Bn 41.30 Bn - -
10 Emergent BioSolutions 335.50 Mn 194.60 Mn 137.20 Mn -53.39%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -53.39%
Mar 31, 2026 6.73%
Dec 31, 2025 -18.76%
Sep 30, 2025 33.10%
Jun 30, 2025 1.14%
Mar 31, 2025 22.46%
Dec 31, 2024 -4.88%
Sep 30, 2024 21.95%
Jun 30, 2024 -79.90%
Mar 31, 2024 13.25%
Dec 31, 2023 -15.84%
Sep 30, 2023 -89.50%
Jun 30, 2023 -86.68%
Mar 31, 2023 -89.84%
Dec 31, 2022 -16.75%
Sep 30, 2022 -18.88%
Jun 30, 2022 -31.45%
Mar 31, 2022 2.26%
Dec 31, 2021 39.13%
Sep 30, 2021 -15.61%
API Access

Emergent BioSolutions Operating Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-margin&ticker=EBS&period=max&api_key=YOUR_API_KEY